L&J-AD

N/A

Report date: 2024/08/23 17:35:40

Base Information

Drug NameL&J-AD
Drug Alias NameL&J-AD
ClassificationBiologics
Mechanisms of ActionAmyloid beta-protein precursor inhibitorsMicrotubule-associated protein tau inhibitors
TargetsAmyloid beta-protein precursorMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesL&J Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesL&J Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A